使用贝叶斯统计重新分析实用性随机最佳血小板与血浆比例试验的数据
该质量改进研究对PROPPR试验进行事后贝叶斯分析,采用多重分层模型评估复苏策略与死亡率的关系。PROPPR试验在12家美国一级创伤中心纳入680例预计需大量输血的严重创伤患者,随机接受1:1:1平衡输血或1:1:2红细胞为主策略。原频率学派分析未发现24小时死亡率(12.7% vs 17.0%;校正RR 0.75 [95%CI 0.52-1.08];P=.12)和30天死亡率(22.4% vs 26.1%;校正RR 0.86 [95%CI 0.65-1.12];P=.26)的显著差异。贝叶斯分析显示1:1:1在24小时和30天死亡率上优于1:1:2的概率分别为93%(贝叶斯因子13.7;RR 0.75 [95%可信区间0.45-1.11])和87%(贝叶斯因子6.56;RR 0.82 [95%可信区间0.57-1.16])。
要点
- PROPPR试验原频率学派分析:24小时死亡率1:1:1组12.7% vs 1:1:2组17.0%,校正RR 0.75(95%CI 0.52-1.08),P=.12,无显著差异。
- 原频率学派分析:30天死亡率1:1:1组22.4% vs 1:1:2组26.1%,校正RR 0.86(95%CI 0.65-1.12),P=.26,无显著差异。
- 贝叶斯分析:1:1:1在24小时死亡率上优于1:1:2的概率为93%(贝叶斯因子13.7;RR 0.75 [95%可信区间0.45-1.11])。
- 贝叶斯分析:1:1:1在30天死亡率上优于1:1:2的概率为87%(贝叶斯因子6.56;RR 0.82 [95%可信区间0.57-1.16])。
- 作者认为,贝叶斯统计方法提供基于概率的结果,可直接比较不同干预,应考虑用于未来评估创伤相关结局的研究。
适用人群与场景
- PROPPR试验纳入680例严重创伤患者,预计需要大量输血,来自12家美国一级创伤中心,时间为2012年8月至2013年12月。
- 人群特征:546例(80.3%)男性;中位(IQR)年龄34(24-51)岁;330例(48.5%)为穿透伤;中位(IQR)损伤严重度评分26(17-41);591例(87.0%)存在严重出血。
处置流程与药物剂量
- PROPPR试验中,患者被随机分配接受平衡输血(血浆、血小板和红细胞等比例,即1:1:1)或红细胞为主策略(1:1:2)进行初始复苏。
研究设计与关键结果
- 研究类型:质量改进研究,对PROPPR试验进行事后贝叶斯分析,采用多重分层模型评估复苏策略与死亡率的关联;数据分析于2021年12月至2022年6月进行。
- 原频率学派主要终点:24小时死亡率1:1:1组12.7% vs 1:1:2组17.0%,校正RR 0.75(95%CI 0.52-1.08),P=.12;30天死亡率1:1:1组22.4% vs 1:1:2组26.1%,校正RR 0.86(95%CI 0.65-1.12),P=.26。
- 贝叶斯分析:1:1:1在24小时死亡率上优于1:1:2的后验概率为93%(贝叶斯因子13.7;RR 0.75 [95%可信区间0.45-1.11]);在30天死亡率上优于1:1:2的后验概率为87%(贝叶斯因子6.56;RR 0.82 [95%可信区间0.57-1.16])。
证据类型、等级与局限
- 证据类型:对PROPPR随机试验数据的事后贝叶斯再分析,属于质量改进研究。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为,对PROPPR试验的事后贝叶斯分析发现证据支持对失血性休克患者采用平衡复苏策略以降低死亡率。
- 作者认为,贝叶斯统计方法提供基于概率的结果,可直接比较不同干预,应考虑用于未来评估创伤相关结局的研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Frequentist statistical approaches are the most common strategies for clinical trial design; however, bayesian trial design may provide a more optimal study technique for trauma-related studies.
OBJECTIVE: To describe the outcomes of bayesian statistical approaches using data from the Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial.
DESIGN, SETTING, AND PARTICIPANTS: This quality improvement study performed a post hoc bayesian analysis of the PROPPR Trial using multiple hierarchical models to assess the association of resuscitation strategy with mortality. The PROPPR Trial took place at 12 US level I trauma centers from August 2012 to December 2013. A total of 680 severely injured trauma patients who were anticipated to require large volume transfusions were included in the study. Data analysis for this quality improvement study was conducted from December 2021 and June 2022.
INTERVENTIONS: In the PROPPR Trial, patients were randomized to receive a balanced transfusion (equal portions of plasma, platelets, and red blood cells [1:1:1]) vs a red blood cell-heavy strategy (1:1:2) during their initial resuscitation.
MAIN OUTCOMES AND MEASURES: Primary outcomes from the PROPPR trial included 24-hour and 30-day all-cause mortality using frequentist statistical methods. Bayesian methods were used to define the posterior probabilities associated with the resuscitation strategies at each of the original primary end points.
RESULTS: Overall, 680 patients (546 [80.3%] male; median [IQR] age, 34 [24-51] years, 330 [48.5%] with penetrating injury; median [IQR] Injury Severity Score, 26 [17-41]; 591 [87.0%] with severe hemorrhage) were included in the original PROPPR Trial. Between the groups, no significant differences in mortality were originally detected at 24 hours (12.7% vs 17.0%; adjusted risk ratio [RR], 0.75 [95% CI, 0.52-1.08]; P = .12) or 30 days (22.4% vs 26.1%; adjusted RR, 0.86 [95% CI, 0.65-1.12]; P = .26). Using bayesian approaches, a 1:1:1 resuscitation was found to have a 93% (Bayes factor, 13.7; RR, 0.75 [95% credible interval, 0.45-1.11]) and 87% (Bayes factor, 6.56; RR, 0.82 [95% credible interval, 0.57-1.16]) probability of being superior to a 1:1:2 resuscitation with regards to 24-hour and 30-day mortality, respectively.
CONCLUSIONS AND RELEVANCE: In this quality improvement study, a post hoc bayesian analysis of the PROPPR Trial found evidence in support of mortality reduction with a balanced resuscitation strategy for patients in hemorrhagic shock. Bayesian statistical methods offer probability-based results capable of direct comparison between various interventions and should be considered for future studies assessing trauma-related outcomes.
参考来源
- Lammers D, Richman J, Holcomb JB, et al. Use of Bayesian Statistics to Reanalyze Data From the Pragmatic Randomized Optimal Platelet and Plasma Ratios Trial. JAMA Netw Open. 2023. PMID: 36811858. doi:10.1001/jamanetworkopen.2023.0421
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。